Establishing Patient Safety Monitoring in the Benefit-Risk Paradigm for Off-Label and Emergency Use of Medications for COVID-19: A Pharmacovigilance Perspective

Malikova, M ; Webster, P ; Brahmbhatt, T

Drug safety, 2022-10, Vol.45 (10), p.1199-1200 [Periódico revisado por pares]

Auckland: Springer Nature B.V

Texto completo disponível